Colitis Clinical Trials 2024

What are the top hospitals conducting colitis research?

In the realm of medical research and innovation, several hospitals have emerged as leaders in conducting clinical trials focused on colitis. One such institution is the Clinical Research Institute of Michigan, LLC, located in Chesterfield. With an impressive eight ongoing colitis trials and a total of 24 completed studies to their name, this facility has been at the forefront of advancing our understanding and treatment options for this condition since embarking on its first trial back in 2004. In Tyler, Texas, the Tyler Research Institute also stands out with eight active colitis trials and a commendable history of 21 past investigations dating back to their initial recorded trial in 2012.

Heading south to Naples, Florida, we find another hub for cutting-edge research on colitis at the Gastroenterology Group of Naples. This esteemed institution currently has six active clinical trials underway while having previously conducted an equally noteworthy tally of 21 studies since initiating their inaugural colitis trial in 2008. Meanwhile, Digestive Health Specialists of the Southeast based in Dothan contribute significantly through their dedication towards fostering advancements against this condition by undertaking six ongoing clinical tests along with thirteen accomplished experiments; theirs can be traced back only ten years ago starting from2012.

Rounding off these top hospitals providing crucial insights into colitis is Atlanta Gastroenterology Associates situated within bustling Atlanta city itself. Despite being home to five active colitis trials at present,Due significance must be given considering it's twenty-six previous groundbreaking investigations that go as far back as20years ago,instituted during2002.

These institutions represent pillars dedicated to unraveling the complexities surrounding colitis—a chronic inflammatory disease affecting thousands worldwide—and transforming lives through ground-breaking research findings.Through tireless efforts across these leading healthcare facilities,collectively working together,a world where patients' suffering fromcolitiscan look forward to brighter futures becomes increasingly promising each day

Which are the best cities for colitis clinical trials?

When it comes to colitis clinical trials, several cities emerge as key centers for research. Miami, Florida leads the pack with 46 active trials investigating treatments like ABX464 50mg and Upadacitinib (ABT-494). New york, New York follows closely behind with 44 ongoing studies focused on medications such as tofacitinib and RPC1063. Houston, Texas also plays a significant role in colitis research with 41 active trials exploring drugs like Ozanimod and Mirikizumab. These cities offer individuals living with colitis the opportunity to participate in cutting-edge clinical trials that pave the way for advancements in treatment options and improved quality of life.

Which are the top treatments for colitis being explored in clinical trials?

In the realm of colitis research, clinical trials are uncovering promising treatments that hold potential for patients. Leading the charge is vedolizumab, currently being explored in three active trials and boasting a track record of 25 all-time colitis trials since its introduction in 2007. Joining vedolizumab in the spotlight is mirikizumab, with three ongoing trials and six all-time colitis studies under its belt since debuting in 2015. Another contender grabbing attention is etrasimod, involved in three active trials and ten all-time colitis studies since its first listing also in 2015. Additionally, fecal microbiota transplantation shows promise with two ongoing trials and ten all-time colitis studies starting from 2012. Finally, remestemcel-L enters the field as a newcomer but already making an impact with two active and two all-time colitis trial listings beginning just last year (2020). With each new study comes hope for better management and treatment options for individuals battling this challenging condition

What are the most recent clinical trials for colitis?

Exciting advancements are being made in the field of colitis treatment through recent clinical trials. One notable trial involves high-dose Budesonide, a medication that shows promise in effectively managing colitis symptoms. Another study focuses on Mirikizumab, which is undergoing Phase 3 testing and holds potential as a therapeutic option for individuals with colitis. Additionally, Efavaleukin Alfa Dose 1 (Low Dose) is currently being evaluated in Phase 2 trials to explore its effectiveness in treating this condition. These ongoing research efforts highlight the commitment to finding improved treatments and better outcomes for patients living with colitis.

What colitis clinical trials were recently completed?

Several clinical trials exploring treatments for colitis have recently concluded, reflecting ongoing efforts to improve management of this condition. In November 2021, Bacainn Therapeutics successfully completed a trial investigating the effectiveness of BT051 200 mg. Another noteworthy study that wrapped up in June 2021 was sponsored by Bridge Biotherapeutics and tested BBT-401-1S. Additionally, Landos Biopharma Inc.'s trial on NX-13 250mg IR reached its completion milestone in May 2021. These recent advancements highlight the commitment of researchers to advance treatments for colitis and offer hope for patients seeking relief from this challenging disease.